AnalystsAydin HuseynovAydin Huseynov's Stock Forecasts
AnalystsAydin Huseynov
Sectors:
Analyst Ranking
Bottom 2%
#4942 out of 5007 analysts
Average Return
-24.93%
Win Rate
34%19 out of 56
Risk vs Reward
Poor
Good
Aydin Huseynov's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Compass Therapeutics IncCMPX | +133.77% | $1.54 | $3.60 | 2022-03-14 - 2023-03-14 | Strong Buy |
Adverum Biotechnologies IncADVM | +131.25% | $8.00 | $18.50 | 2023-03-06 - 2024-03-06 | Strong Buy |
Compass Therapeutics IncCMPX | +101.17% | $1.71 | $3.44 | 2024-09-15 - 2025-09-05 | Strong Buy |
Trillium Therapeutics IncTRIL | +80.08% | $10.24 | $18.44 | 2021-04-13 - 2021-11-16 | Strong Buy |
Urogen Pharma LtdURGN | +74.49% | $10.82 | $18.88 | 2025-02-18 - 2025-09-05 | Strong Buy |
Aydin Huseynov Analyst Color
Get additional color on Aydin Huseynov's coverage of popular stocks
Aydin Huseynov's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ardelyx IncARDX | 1 | Strong Buy | $11.00 | +68.71% | Assumes | 6 months ago |
Urogen Pharma LtdURGN | 1 | Strong Buy | $31.00 | +64.19% | Assumes | 7 months ago |
Marker Therapeutics IncMRKR | 2 | Strong Buy | $19.00 | +2,018.17% | Maintains | a year ago |
Corvus Pharmaceuticals IncCRVS | 3 | Strong Buy | $21.00 | +240.91% | Maintains | a year ago |
Compass Therapeutics IncCMPX | 2 | Strong Buy | $5.00 | +45.35% | Upgrades | a year ago |
Acrivon Therapeutics IncACRV | 2 | Strong Buy | $16.00 | +1,103.01% | Upgrades | a year ago |
Calidi Biotherapeutics IncCLDI | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | a year ago |
Capricor Therapeutics IncCAPR | 2 | Strong Buy | $25.00 | N/A | Maintains | a year ago |
Rein Therapeutics IncRNTX | 2 | Strong Buy | $19.00 | N/A | Maintains | a year ago |
Biodexa Pharmaceuticals PLCBDRX | 1 | Strong Buy | $2,000.00 | N/A | Initiates Coverage On | 2 years ago |
Pmv Pharmaceuticals IncPMVP | 1 | Strong Buy | $7.00 | N/A | Initiates Coverage On | 2 years ago |
Zura Bio LtdZURA | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Coeptis Therapeutics Holdings IncCOEP | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 2 years ago |
Cognition Therapeutics IncCGTX | 2 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Alterity Therapeutics LtdATHE | 3 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Palisade Bio IncPALI | 2 | Strong Buy | $240.00 | N/A | Maintains | 2 years ago |
Tempest Therapeutics IncTPST | 2 | Strong Buy | $14.00 | N/A | Maintains | 2 years ago |
Processa Pharmaceuticals IncPCSA | 1 | Buy | $80.00 | N/A | Maintains | 2 years ago |
Adverum Biotechnologies IncADVM | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Metavia IncMTVA | 1 | Strong Buy | $48.00 | N/A | Initiates Coverage On | 3 years ago |
Calithera Biosciences IncCALA | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Nextcure IncNXTC | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Satsuma Pharmaceuticals IncSTSA | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 3 years ago |
Allarity Therapeutics IncALLR | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Anebulo Pharmaceuticals IncANEB | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Nuvectis Pharma IncNVCT | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 3 years ago |
Quoin Pharmaceuticals LtdQNRX | 1 | Strong Buy | $10,500.00 | N/A | Initiates Coverage On | 3 years ago |
Annovis Bio IncANVS | 1 | Strong Buy | $37.00 | N/A | Initiates Coverage On | 3 years ago |
Spruce Biosciences IncSPRB | 2 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Bellicum Pharmaceuticals IncBLCM | 2 | Strong Buy | $5.00 | N/A | Initiates Coverage On | 4 years ago |
Trillium Therapeutics IncTRIL | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Nektar TherapeuticsNKTR | 3 | Strong Buy | $300.00 | N/A | Upgrades | 4 years ago |
Regeneron Pharmaceuticals IncREGN | 6 | Hold | N/A | N/A | Downgrades | 4 years ago |
Incyte CorpINCY | 2 | Strong Buy | $89.00 | N/A | Upgrades | 4 years ago |
Scopus Biopharma IncSCPS | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 5 years ago |
Neurocrine Biosciences IncNBIX | 1 | Hold | N/A | N/A | Initiates Coverage On | 5 years ago |
Salarius Pharmaceuticals IncSLRX | 1 | Buy | $15,000.00 | N/A | Initiates Coverage On | 5 years ago |
Inovio Pharmaceuticals IncINO | 1 | Strong Buy | $336.00 | N/A | Initiates Coverage On | 5 years ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.